Learn about MeMed's host
immune response technology at
MeMed is transforming patient care by listening to the immune system and turning host response signals into clinical action.
MeMed's AWARD Winning Technology!
Dr. Eran Eden
Co-founder and CEO of MeMed
MeMed: A Leader in Host Response Technology
What would your antibiotic stewardship program look like if you had a 15-minute test that could differentiate between a bacterial and viral infection? MeMed BV® is the first rapid and accurate (blinded and external validation) host-response technology for distinguishing between bacterial and viral infections in under 15 minutes, and it is changing the paradigm in infectious disease patient management.
AACC Poster Presentations
At MeMed, a leader in host response technologies, we decode the body's complex signals into simple insights that improve people's lives. By leveraging our expertise in host-response profiling and machine-learning algorithms, we are creating a portfolio of tests that address tough clinical dilemmas.
Importantly, with the support of public and private partnerships, we have developed a point-of-need, rapid measurement platform called MeMed Key to ensure timely availability of these novel tests during the clinician’s decision-making workflow.